Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q93796

Entry ID Method Resolution Chain Position Source
AF-Q93796-F1 Predicted AlphaFoldDB

No variants for Q93796

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q93796

3 associated diseases with Q93796

[MIM: 176430]: Premature chromatid separation trait (PCS)

Consists of separate and splayed chromatids with discernible centromeres and involves all or most chromosomes of a metaphase. It is found in up to 2% of metaphases in cultured lymphocytes from approximately 40% of normal individuals. When PCS is present in 5% or more of cells, it is known as the heterozygous PCS trait and has no obvious phenotypic effect, although some have reported decreased fertility. Inheritance is autosomal dominant. {ECO:0000269|PubMed:16411201}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 257300]: Mosaic variegated aneuploidy syndrome 1 (MVA1)

A severe developmental disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases. {ECO:0000269|PubMed:15475955}. Note=The disease is caused by variants affecting the gene represented in this entry. MVA1 is caused by biallelic mutations in the BUB1B gene.

Without disease ID
  • Consists of separate and splayed chromatids with discernible centromeres and involves all or most chromosomes of a metaphase. It is found in up to 2% of metaphases in cultured lymphocytes from approximately 40% of normal individuals. When PCS is present in 5% or more of cells, it is known as the heterozygous PCS trait and has no obvious phenotypic effect, although some have reported decreased fertility. Inheritance is autosomal dominant. {ECO:0000269|PubMed:16411201}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A severe developmental disorder characterized by mosaic aneuploidies, predominantly trisomies and monosomies, involving multiple different chromosomes and tissues. Affected individuals typically present with severe intrauterine growth retardation and microcephaly. Eye anomalies, mild dysmorphism, variable developmental delay, and a broad spectrum of additional congenital abnormalities and medical conditions may also occur. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor and leukemia reported in several cases. {ECO:0000269|PubMed:15475955}. Note=The disease is caused by variants affecting the gene represented in this entry. MVA1 is caused by biallelic mutations in the BUB1B gene.

1 regional properties for Q93796

Type Name Position InterPro Accession
domain Mad3/Bub1 homology region 1 55 - 226 IPR013212

Functions

Description
EC Number
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

1 GO annotations of molecular function

Name Definition
phosphatidylserine binding Binding to phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine.

2 GO annotations of biological process

Name Definition
lipid transport The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
positive regulation of engulfment of apoptotic cell Any process that activates or increases the frequency, rate or extent of engulfment of apoptotic cell.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8SPF8 BPIFB1 BPI fold-containing family B member 1 Bos taurus (Bovine) PR
Q8NFQ5 BPIFB6 BPI fold-containing family B member 6 Homo sapiens (Human) PR
Q8C186 Bpifc BPI fold-containing family C protein Mus musculus (Mouse) PR
10 20 30 40 50 60
MSRNFHIFFL LVSIIQVGNS ADSSEITHKP AGIYVRLNQK AVDYVADLAS DALPAILNNL
70 80 90 100 110 120
SPPDIVTDMA KITKLHISNV AKPNLSAKFI DGKGVAYNIS LASFRASAYA EISVFVWSYE
130 140 150 160 170 180
GDFTAELREL SIESELHFDY NGTTTVNASV CNVTHSELSL VFPPGSSLSA LQSEIKGQIV
190 200 210 220 230 240
SALRDAVCTT AVEALTFVMA QKPIPPESPN YQKPEAGDPN GFSVAELGAS LCQVDTVNGF
250 260 270 280 290 300
EDSEQEEGNV ETTVAPTPDD DNSTLTTEET QKSYWGVDLS VNHPPTFTDE DMIIGLDGGI
310 320 330 340 350 360
LFNGWKADSA QQLQILNKTR LDKKMVGILL SEYIPNTLFH HIYMYDLGNF KHRYTPSSLP
370 380 390 400 410 420
KILQKLSKAV CSKCYVEVSA NLTEQPILQI DAHLGARVQL SGNVSIMFHG REQLHDVLHA
430 440 450 460 470 480
NTKLHVTLKP TVRHSRIFGD VSLTNVDVNV FDLGLGGPLA APIEKLFSFV VPRVLWPQVK
490 500 510 520 530 540
KRLRFAMNRR GVKLPIFCGV ELEHTELDFV DHAVLLNTDF SFDLPLFLAK FKKYLDAKSK
550
INPNLPKYVI I